Pivotal announced today that it has been contracted by Checkpoint Therapeutics Inc., a New York City-based biotechnology company, to provide expert clinical research services in Europe for its upco...
Read moreEl pasado martes 27 de octubre arrancó Acceleration Program, hasta ahora IQS Next Tech (ha cambiado el nombre en esta nueva edición), el programa de aceleración de IQS Tech Factory, el centro de em...
Read moreGenetracer Biotech, startup de biotecnología especializada en la detección precoz de cáncer y Medicina Personalizada de Precisión, ha dado un paso más en la monitorización y neutralización de l...
Read moreLatest advances in the framework of the SMART-4-FABRY project have been shared in both virtual events.
Read moreA team of researchers led by Timothy Thomson's group from the Barcelona Institute of Molecular Biology (IBMB-CSIC), based at the Barcelona Science Park, has developed a platform that allows to see i...
Read moreInvestigadores del Clínic-IDIBAPS y la Universidad de Padua (Italia) han desarrollado un biomarcador llamado HER2DX que predice el pronóstico de las pacientes con cáncer de mama HER2 + en estadios ...
Read moreDesde el pasado mes de marzo, la sociedad en general, y sectores específicos como las funerarias, en particular, estamos viviendo unos tiempos ciertamente complicados.
Read moreThings are going well for your latest drug molecule - it seems efficacious, you have assessed potential toxicity, and even determined a safe starting dose, and now you are ready to move to the clinic...
Read moreThe life science company Sartorius successfully closed the acquisition of the Slovenian purification specialist BIA Separations. The transaction was completed on November 2, 2020, after receiving the ...
Read moreAzbil Corporation announced it has established new numerical targets for essential goals of the Group in the field of Sustainable Development Goals (SDGs). In pursuit of achieving a sustainable societ...
Read moreLa combinación de lo natural y lo artificial con fines terapéuticos adquiere un nuevo estímulo con el último hallazgo del grupo del CiQUS de la USC liderado por Juan Granja. El estudio publicado e...
Read morePharmaceutical companies and public health officials are leveraging experience with the well-known influenza vaccine to support successful development, production and administration of a vaccine(s) ag...
Read more